Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Primary Cerebral Hemorrhage
NCT04742205Phase 3Completed
- Sponsor
- Kathmandu Medical College and Teaching Hospital
- Start
- Feb 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid in intracerebral hemorrhage (ICH), sponsored by Kathmandu Medical College and Teaching Hospital. Started Feb 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT04742205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04742205.